Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE:300832)
China flag China · Delayed Price · Currency is CNY
52.05
-0.35 (-0.67%)
Feb 13, 2026, 3:04 PM CST

SHE:300832 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
1,307919.531,048483.43617.581,075
Short-Term Investments
--275.79110.09--
Trading Asset Securities
953.211,7232,0802,8142,8062,300
Cash & Short-Term Investments
2,2602,6433,4043,4073,4243,375
Cash Growth
-12.61%-22.36%-0.09%-0.49%1.46%70.44%
Accounts Receivable
1,029957.49631.78479.97276.1218.35
Other Receivables
8.33147.9880.6642.8312.692.77
Receivables
1,0371,105712.44522.79288.79221.13
Inventory
1,0001,198916.79839.33645.38459.29
Prepaid Expenses
11.2923.727.4432.29104.7548.32
Other Current Assets
894.5185.7523.0920.834.1621.48
Total Current Assets
5,2035,0565,0644,8224,4974,125
Property, Plant & Equipment
1,7791,6941,4421,3251,134803.51
Long-Term Investments
1,5961,926924.95357.62136.9-
Other Intangible Assets
240.58245.06169.46172.4894.5698.91
Long-Term Accounts Receivable
371.59310.8189.1793.8528.1-
Long-Term Deferred Tax Assets
85.563.9837.9422.912.1422.73
Long-Term Deferred Charges
132.31150.83156.6969.0874.9777.56
Other Long-Term Assets
168.27173.35238.22150.77157.39178.06
Total Assets
9,5779,6198,2227,0156,1365,306
Accounts Payable
232.89456.62126.99176.68171.3598.26
Accrued Expenses
167.11200.59187.77149.03124.27121.78
Current Portion of Leases
1.851.341.691.321.35-
Current Income Taxes Payable
141.22120.14120.3576.1959.9295.9
Current Unearned Revenue
61.3480.1391.48108.9477.0871.06
Other Current Liabilities
76.0849.9163.271.7873.96105.74
Total Current Liabilities
680.5908.74591.48583.94507.94492.74
Long-Term Leases
22.763.490.890.88-
Long-Term Unearned Revenue
42.0347.2633.065.816.588.74
Long-Term Deferred Tax Liabilities
100.8778.5150.0624.418.11-
Other Long-Term Liabilities
6.585.58----
Total Liabilities
831.981,043678.09615.06523.51501.49
Common Stock
785.72785.72785.72786.13786.66412.35
Additional Paid-In Capital
1,3321,3321,3321,3481,4501,601
Retained Earnings
6,6006,4175,3744,2673,4112,850
Treasury Stock
----16.29-37.51-58.55
Comprehensive Income & Other
26.5741.7252.713.991.64-0.33
Shareholders' Equity
8,7458,5777,5446,3995,6124,804
Total Liabilities & Equity
9,5779,6198,2227,0156,1365,306
Total Debt
3.854.15.182.222.24-
Net Cash (Debt)
2,2562,6393,3993,4053,4223,375
Net Cash Growth
-12.61%-22.36%-0.17%-0.49%1.40%70.44%
Net Cash Per Share
2.873.364.334.334.354.50
Filing Date Shares Outstanding
785.72785.72785.72786.13786.66783.47
Total Common Shares Outstanding
785.72785.72785.72786.13786.66783.47
Working Capital
4,5224,1474,4734,2383,9893,632
Book Value Per Share
11.1310.929.608.147.136.13
Tangible Book Value
8,5048,3327,3756,2275,5174,705
Tangible Book Value Per Share
10.8210.609.397.927.016.01
Buildings
-1,0611,061541.55516.8504.42
Machinery
-811.8659.08512.48427.32313.43
Construction In Progress
-414.56169.32605.7442.99172.23
Source: S&P Global Market Intelligence. Standard template. Financial Sources.